Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve the unaudited financial results of the Company for the 02nd quarter and half-year ended September 30, 2026.

26th October, 2026 Listing Department Listing & Compliance Department Bombay Stock Exchange Ltd (BSE) National Stock Exchange, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor Plot No.C/1, 'G' Block Dalal Street, Mumbai - 400 001. Bandra - Kurla Complex, Mumbai - 400 051. Scrip Code - 543308 Symbol - KIMS ISIN: INE967H01025 ISIN: INE967H01025 Subject: Notice of Board Meeting Ref: Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir/Madam, Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of Krishna Institute of Medical Sciences Limited is scheduled to be held on Wednesday, November 04, 2026 inter alia to consider and approve the unaudited (Standalone & Consolidated) financial results of the company for the 02nd quarter and half-year ended September 30, 2026. Further, in accordance with the Company’s Code of Conduct for the Prevention of Insider Trading, the Company has intimated its ‘designated persons’ regarding the closure of the Trading Window for trading in the Company’s equity shares from Thursday i.e., October 01, 2026 till the expiry of 48 hours from the date the said financial results are made public. Kindly take this intimation on your record. Thanking you, Yours truly For Krishna Institute of Medical Sciences Limited Nagajayanthi J.R Company Secretary & Compliance Officer Krishna Institute of Medical Sciences Limited D.No.: 1-8-31/1, Minister Road, Secunderabad - 500 003, Telangana, India Phone: +91 40 4488 5000/4488 5184 | Fax: +91-40-27840980 | kimshospitals.com CIN: L55101TG1973PLC040558